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associated with an enhanced apoptotic response and a reduced protective
response by the cells. This study suggests that ER stress has an important
role in the pathology of cartilage degeneration.
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HYPOXIA INHIBITS HYPERTROPHIC DIFFERENTIATION AND
ENDOCHONDRAL OSSIFICATION IN EXPLANTED TIBIAE
J. Leijten, N. Georgi, E. Landman, L. Moreira Teixeira, C. van Blitterswijk,
M. Karperien. Univ. Twente, Enschede, Netherlands
Purpose: During development, mesenchymal progenitor cells ﬁrst
condense and then differentiate into chondrocytes to form a cartilaginous
template of the future long bone. Most of these chondrocytes
eventually undergo hypertrophic differentiation leading to cartilage
matrix mineralization, chondrocyte apoptosis, and in growth of blood
vessels. As a result, hypertrophic cartilage is alleviated from the
otherwise hypoxic conditions normally present in the avascular cartilage.
In the current study, we addressed the question whether this change in
oxygen level from hypoxia towards normoxia is a mere consequence
of angiogenesis or a driving factor in hypertrophic differentiation and
subsequent endochondral ossiﬁcation.
Methods: Fetal mouse tibiae (E17.5) were explanted from timed-
pregnant mice and cultured up to 21 days either under normoxic
conditions (21% oxygen) or under hypoxic conditions (2.5% oxygen) with
or without 50 or 500ng/ml recombinant Grem1, Frzb and Dkk1 protein.
Previously we have shown that these secreted Wnt- and BMP antagonists
were able to prevent hypertrophy in chondrogenically differentiating
MSCs. Growth kinetics was analyzed using microscopical evaluation.
At designated time points explants were ﬁxated and embedded in
parafﬁn. Five micrometer sections were stained with Alcian blue and
Alizarin red S for histological evaluation of hypertrophic differentiation
and endochondral ossiﬁcation. Image analysis was performed using the
Image J software package. Cartilaginous ends of the tibiae were isolated
and subjected to gene expression analysis using RT-qPCR and protein
expression analysis using ELISA.
Results: Explanted tibiae cultured under normoxic conditions became
signiﬁcantly more elongated compared to tibiae cultured under hypoxic
conditions. Remarkably, macroscopic and histological analysis showed
that the cartilaginous area of the primary physis became signiﬁcantly
larger in hypoxia. Strikingly, tibiae cultured under normoxic conditions
progressively increased the width of the hypertrophic zone and
decreased their resting zone, while under hypoxic conditions the
opposite phenomenon was observed. Moreover, the calciﬁed area
of hypertrophic cartilage was signiﬁcantly larger under normoxic
conditions. Although the length of calciﬁed tissue was signiﬁcantly
shorter under hypoxic conditions, it was more extensively calciﬁed. Gene
expression analysis showed that under normoxic conditions hypertrophic
marker genes such as MMP9, MMP13, RUNX2, COL10A1 and ALPL were
signiﬁcantly higher expressed compared to hypoxic conditions. In
contrast, under hypoxic conditions markers for hyaline cartilage such
as Acan, Col2a1 and Sox9 and secreted articular cartilage markers Grem1,
Frzb and Dkk1 were signiﬁcantly higher expressed. Indeed, addition of
Grem1, Frzb and Dkk1 to explanted tibiae cultured under normoxia
mitigated longitudinal growth, by inhibiting hypertrophic differentiation
and endochondral ossiﬁcation, in a concentration dependent manner.
Conclusions: Collectively our data suggests that oxygen levels play
a powerful role in the terminal differentiation of hypertrophic
chondrocytes and formation of endochondral bone. Where normoxia
induces up regulation of hypertrophic related genes, hypoxia triggers
tibiae to produce chondrogenic markers and suppressed hypertrophic
differentiation at least partially by stimulating the expression of the
secreted antagonists Grem1, Frzb and Dkk1. Together this suggests
that the higher oxygen levels, as found in the hypertrophic zone,
actively contribute to the hypertrophic differentiation of cartilage and
its subsequent endochondral ossiﬁcation.
207
INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN (mTOR)
INDUCES AUTOPHAGY IN ARTICULAR CARTILAGE AND REDUCES
SEVERITY OF EXPERIMENTAL OSTEOARTHRITIS
B. Carame´s1, A. Hasegawa1, N. Taniguchi1, F. Blanco2, R. Terkeltaub3,
M. Lotz1. 1The Scripps Res. Inst., La Jolla, CA, USA; 2Ostearticular and Aging
Res. Lab, INIBIC-Complejo Hosp.ario Univ.rio A Corun˜a, A Corun˜a, Spain;
3Dept. of Med., Univ. of California, San Diego, La Jolla, CA, USA
Purpose: Osteoarthritis (OA) is characterized by insufﬁcient extracellular
matrix synthesis and articular cartilage degradation. Autophagy is
an essential cellular homeostasis mechanism for the removal of
dysfunctional intracellular macromolecules and organelles. Previous
ﬁndings indicated deﬁcient autophagy in aging and OA cartilage. The
Mammalian Target of Rapamycin (mTOR) is a key inhibitor of autophagy.
In this study we determined whether inhibition of the mTOR pathway
is associated with disease-modifying activity in experimental OA.
Methods: Experimental OA was induced by transection of the
medial meniscotibial ligament and the medial collateral ligament
(MMTL+MCL) in 2-month old C57Bl/6 mice (n =36). Rapamycin (1mg/kg
weight/day) (n = 18 mice) or DMSO vehicle control (n = 18 mice) were
administered intraperitoneally for 10 weeks. The morphological changes
in the articular cartilage and synovium were examined by histology
using semiquantitative scoring systems. Immunohistochemical and
immunoﬂuorescence staining were employed to analyze the effect
of rapamycin on mTOR signaling pathway, autophagy and cartilage
homeostasis.
Results: Intraperitoneal rapamycin treatment affected the mTOR
signaling pathway in mouse knee joints as indicated by inhibition
of prbS6, a direct target of mTOR and activation of LC3, a main
marker of autophagy. The rate of progressive cartilage degeneration in
mouse knee joints after surgical destabilization of the medial meniscus
was signiﬁcantly reduced (P < 0.01) in the rapamycin treated group
compared to the vehicle treated group. In addition, the histological
evaluation showed a signiﬁcant decrease in synovitis (P< 0.05) after
rapamycin treatment. The effect of rapamycin was directly correlated
with maintenance of cartilage cellularity and a decrease in ADAMTS-5
expression in mouse knee joints.
Conclusion: These results suggest that inhibition of mTOR reduces
cartilage degeneration and OA progression in experimental OA.
Pharmacological inhibition of mTOR by rapamycin or other agents may
be a potentially effective therapeutic approach for the treatment of OA.
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REDUCED IGF SIGNALING MAY BE RESPONSIBLE FOR THE DECLINE
IN CARTILAGE MATRIX GENE EXPRESSION IN DEGENERATED AREAS
WITHIN OSTEOARTHRITIC CARTILAGE
N. Fukui1,2, N. Tanaka2, Y. Ikeda2, T. Yamaguchi2, Y. Miyamoto3,
T. Tashiro4, Y. Katsuragawa5. 1Graduate Sch. of Arts and Sci., The Univ. of
Tokyo, Tokyo, Japan; 2Clinical Res. Ctr., Natl. Hosp. Organization Sagamihara
Hosp., Sagamihara, Japan; 3Tokyo Metropolitan Geriatric Hosp., Tokyo,
Japan; 4JR Tokyo Gen. Hosp., Tokyo, Japan; 5Natl. Ctr. for Global Hlth.and
Med., Tokyo, Japan
Purpose: In osteoarthritis (OA), cartilage undergoes degenerative
changes primarily in the weight bearing areas. Previous studies have
shown that the expression of type II collagen and aggrecan is obviously
elevated in preserved areas, but it is considerably attenuated in
degenerated areas. Although this decline in matrix gene expression could
be involved in the loss of cartilage in OA, a mechanism for the decline
has not yet been elucidated. The purpose of this study was to clarify this
mechanism through the analyses of human cells and cartilage samples.
Methods: This study was performed under the approval of an
institutional review board. RNA was obtained from 10 end-stage OA
cartilages at degenerated and preserved areas, respectively, and gene
expression proﬁles were determined in respective RNA samples by
cDNA microarray. The result of microarray analysis was conﬁrmed
by qPCR analysis combined with laser capture microdissection (LCM;
Pixell II, Arcturus) for accurate acquisition of cartilage tissues from
speciﬁc regions. The result of gene expression analysis was conﬁrmed
by immunohistochemistry and protein quantiﬁcation of tissue extracts
by BioPlex (BioRad). A signal pathway involved in the decline in
matrix gene expression in degenerated areas was speciﬁed by explant
culture experiments. RNAi and adenoviral transduction experiments were
performed to elucidate the underlying mechanism for the decline.
Poster Presentations / Osteoarthritis and Cartilage 19S1 (2011) S53–S236 S103
Figure: Expression of IGF1R (A), IRS1 (B), IGFBP1 (C), IGFBP3 (D), IGFBP5 (E)
and IGFBP6 (F) in preserved and degenerated areas of human OA cartilage.
Results of qPCR analysis coupled with laser capture microdissection.
Pres, preserved area; Deg, degenerated area. **p< 0.01 against preserved
areas.
Results: Using microarray data, expression of possible anabolic factors
for chondrocytes (growth factors and anabolic cytokines) and related
molecules (receptors, antagonists and molecules related to signal
transduction) was compared between the degenerated areas and
preserved areas. This comparison revealed that the expression of IGF1R
and IRS1 could be reduced, and the expression of IGF-BP1, 3, 5 and 6
could be increased in degenerated areas. These ﬁndings were conﬁrmed
by qPCR analysis combined with LCM (Figure). The reduction in IGF1R
and IRS1 and the increase in IGF-BP3 and 5 in degenerated areas
were conﬁrmed by immunohistochemistry and protein quantiﬁcation
by BioPlex. These results indicated that the reduced response to IGFs
could account for the decline in cartilage matrix gene expression in
degenerated areas.
Next, cartilage explants were prepared from degenerated and preserved
areas, respectively, and treated with speciﬁc inhibitors for Akt signaling,
the dominant signal pathway activated by IGFs. This treatment reduced
the expression of type II collagen and aggrecan only in the explants
from preserved areas, but such a reduction was not observed in those
from degenerated areas, suggesting that Akt signaling had been already
attenuated in vivo in the degenerated areas.
In a variety of cells, expression of IGF1R and IRS1 is regulated by Sp1.
Thus, we investigated Sp1 expression within OA cartilage, and found that
its expression was obviously reduced in degenerated areas. We also found
that the expression levels of IGF1R and IRS1 were signiﬁcantly correlated
with that of Sp1 within human OA cartilage. Thus, in the degenerated
areas of OA cartilage, the expression of IGF1R and IRS1was considered
to be attenuated by the reduction in Sp1 expression. To conﬁrm this,
the expression of Sp1 in primary cultured human chondrocytes was
suppressed by RNAi or elevated by adenoviral transduction, which
indeed caused the increase or reduction of IGF1R and IRS1 expression,
respectively.
Conclusions: The result of this study has shown that the response of
chondrocytes to IGFs might be reduced in the degenerated areas of OA
cartilage. Since OA synovial ﬂuid contains substantial amounts of IGF-1,
reduced response to IGFs may well account for the decline in cartilage
matrix expression in degenerated areas within OA cartilage.
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IN END STAGE OSTEOARTHRITIS, CARTILAGE TISSUE PENTOSIDINE
LEVELS ARE INVERSELY RELATED TO PARAMETERS OF CARTILAGE
DAMAGE
P. Vos1, S. Mastbergen1, T. deBoer1, M. Huisman2, A. Polak2, J. deGroot3,
F. Lafeber1. 1Rheumatology & Clinical Immunology, Univ. Med. Ctr. Utrecht,
Utrecht, Netherlands; 2Sint Franciscus Gasthuis, Rotterdam, Netherlands;
3Business unit BioSci., TNO Quality of Life, Leiden, Netherlands
Purpose: Age is the most prominent predisposition for development
of osteoarthritis (OA), a slowly progressive joint disease characterized
by gradual loss of articular cartilage. Age-related changes of articular
cartilage are likely to play a role. Advanced glycation endproducts (AGEs)
accumulate in the cartilage matrix with increasing age and adversely
affect the biomechanical properties of the cartilage matrix and inﬂuences
chondrocyte activity. These effects render the tissue more prone to
damage and may potentially lead to the development of OA. In clinical
studies AGEing of cartilage and its relation to actual cartilage damage
can only be measured by surrogate markers (e.g. serum, skin or urine
AGE levels and imaging or biochemical markers of cartilage damage).
Relations between AGEing and cartilage damage are found although
results are far from conclusive, maybe due to the limited relation
between cartilage AGE levels and AGE levels of surrogate compartments
or surrogate markers of cartilage damage. Thus far, a direct comparison
between cartilage AGE level and actual cartilage damage has not been
made. Therefore, the present study compares actual cartilage AGE levels
(in addition to urinary AGE levels) in OA directly with actual cartilage
damage by use of macroscopic, histological and biochemical analyses.
Methods: Cartilage from the femoral condyles of 69 knee OA patients
(average age: 68.8±9.0 years; 50/19 female/male ratio) undergoing
total knee replacement and urine samples were obtained and analysed
for pentosidine as marker of AGE. Cartilage damage was evaluated
by macroscopic, histological, and biochemical analyses (proteoglycan
turnover).
Results: Cartilage and urine pentosidine both increased with increasing
age (R =0.493 and R=0.535 resp. both with p =0.000) as previously found.
The higher the macroscopic cartilage damage the lower the cartilage
pentosidine amount (R = −0.286, p = 0.028). This inverse relation was also
found when related to the histological cartilage damage (R = −0.428,
p = 0.001). The biochemical analysis of cartilage damage corroborated
this as the different proteoglycan parameters also demonstrated an
inverse relation with cartilage pentosidine levels (PG content R =0.179,
p=NS; %PG synthesis R = 0.443, p = 0.000; % total PG released R=−0.392,
p = 0.002; and % newly formed GAG released R=−0.400, p = 0.002). Four
urine pentosidine similar results were found (R =0.057, ns; PG synthesis
rate: R = 0.279, p = 0.032; total PG release: R = −0.288, p = 0.027; newly
formed GAG release: R = −0.248, ns). In multiple regression analysis this
relationship seems to be independent of age. For cartilage histology, PG
synthesis, % total PG and newly formed GAG released as independent
variable and age as well as cartilage pentosidine as dependent variable in
most cases the explained variance was around 40% (R2 ≈0.4). The partial
regression coefﬁcient (B) was not signiﬁcant for age, but in all cases it
was for cartilage pentosidine.
Conclusions: There is an inverse relation between cartilage AGEs and
actual cartilage damage measured on different levels in end stage OA
using the cartilage tissue itself. This is contrasting the existing literature,
which show positive relations making use of indirect measurements. This
difference might be explained by the fact that in case of more severe
OA, the cartilage can contain lower amount of pentosidine due to newly
formed collagen not yet modiﬁed by the non-enzymatic glycation. What
the exact contribution of AGEs to OA progression is remains ambiguous.
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HUMAN END-STAGE OA CARTILAGE IS RESPONSIVE TO TGF BETA
AND CONTAINS A POPULATION OF CELLS THAT EXPRESSES SMAD2/3P
AND SMAD1/5/8P
A. van Caam, E. Blaney Davidson, E. Vitters, W. van den Berg, P. van der
Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Background: Joint diseases such as osteoarthritis (OA) result in
destruction of articular cartilage. Transforming Growth factor beta is
considered as a protective factor in young cartilage while this function is
lost upon aging. In chondrocytes, TGF beta can signal via phosphorylation
of SMAD2/3 (via ALK5) or SMAD1/5/8 (via ALK1). In earlier studies
we have found that in young healthy human cartilage (age < 10 years)
only SMAD2/3 phosphorylation (SMAD2/3P) occurs and no SMAD1/5/8
phosphorylation (SMAD1/5/8P). Moreover, in human OA cartilage we
showed a signiﬁcant correlation between ALK1 and MMP13 expression.
Purpose: To study the expression of SMAD2/3P and SMAD1/5/8P in
chondrocyte populations in end-stage human OA cartilage and whether
addition of exogenous TGF beta modulates the expression of MMP13,
ALK5 and ALK1 in this cartilage.
Methods: Human OA articular cartilage was obtained during knee joint
replacement (n =20). Cartilage sections were stained for SMAD2/3P and
SMAD1/5/8P using speciﬁc antibodies. In addition, human OA cartilage
was incubated with 10ng/ml TGF beta for 24h. Part of the cartilage
